dCK expression and gene polymorphism with gemcitabine chemo-sensitivity in patients with pancreatic ductal adenocarcinoma

被引:0
|
作者
Altaf, K. [1 ]
Xiong, J. [2 ]
Ke, N. [2 ]
Wang, Y. [2 ]
Liu, X. [2 ]
机构
[1] NHS Fdn Trust, Warrington & Halton Hosp, Warrington, Cheshire, England
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
0418
引用
收藏
页码:36 / 37
页数:2
相关论文
共 50 条
  • [31] Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
    Venkat, Swati
    Tisdale, Arwen A.
    Schwarz, Johann R.
    Alahmari, Abdulrahman
    Maurer, H. Carlo
    Olive, Kenneth
    Eng, Kevin H.
    Feigin, Michael E.
    GENOME RESEARCH, 2020, 30 (03) : 347 - 360
  • [32] Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function
    Yoshito Tomimaru
    Hidetoshi Eguchi
    Yoshifumi Iwagami
    Hirofumi Akita
    Takehiro Noda
    Kunihito Gotoh
    Shogo Kobayashi
    Hiroaki Nagano
    Masaki Mori
    Yuichiro Doki
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 537 - 545
  • [33] Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Koltai, Tomas
    Reshkin, Stephan Joel
    Carvalho, Tiago M. A.
    Di Molfetta, Daria
    Greco, Maria Raffaella
    Alfarouk, Khalid Omer
    Cardone, Rosa Angela
    CANCERS, 2022, 14 (10)
  • [34] Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function
    Tomimaru, Yoshito
    Eguchi, Hidetoshi
    Iwagami, Yoshifumi
    Akita, Hirofumi
    Noda, Takehiro
    Gotoh, Kunihito
    Kobayashi, Shogo
    Nagano, Hiroaki
    Mori, Masaki
    Doki, Yuichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 537 - 545
  • [35] HENT1 AND DCK EXPRESSION PREDICT BENEFIT FROM GEMCITABINE AFTER CURATIVE-INTENT RESECTION IN PANCREATIC ADENOCARCINOMA
    Marechal, Raphael
    Bachet, Jean-Baptiste
    Mackey, John R.
    Demetter, Pieter
    Graham, Kathryn
    Couvelard, Anne
    Svrcek, Magali
    Bardier-Dupas, Armelle
    Hammel, Pascal
    Sauvanet, Alain
    Louvet, Christophe
    Paye, Francois
    Rougier, Philippe
    Hannoun, Laurent
    Andre, Thierry
    Cass, Carol E.
    Salmon, Isabelle
    Emile, Jean-Francois
    Van Laethem, Jean-Luc
    ANNALS OF ONCOLOGY, 2011, 22 : v12 - v12
  • [36] Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression
    Zhang, Zhao-Yue
    Sun, Zi-Jie
    Gao, Dong
    Hao, Yu-Duo
    Lin, Hao
    Liu, Fen
    IET SYSTEMS BIOLOGY, 2024, 18 (06) : 261 - 270
  • [37] SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
    Ughur Aghamaliyev
    Kaifeng Su
    Maximilian Weniger
    Dominik Koch
    Jan G. D‘Haese
    Jens Werner
    Alexandr V. Bazhin
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 9191 - 9200
  • [38] SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
    Aghamaliyev, Ughur
    Su, Kaifeng
    Weniger, Maximilian
    Koch, Dominik
    D'Haese, Jan G.
    Werner, Jens
    Bazhin, Alexandr V.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 9191 - 9200
  • [39] Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma
    Pignon, Flore
    Turpin, Anthony
    Hentic, Olivia
    Coriat, Romain
    Salmon, Emma
    Baumgaertner, Isabelle
    Bertrand, Nicolas
    Levy, Philippe
    Rebours, Vinciane
    Hammel, Pascal
    de Mestier, Louis
    PANCREATOLOGY, 2021, 21 (06) : 1064 - 1070
  • [40] Pancreatic ductal adenocarcinoma in young patients
    Pernick, NL
    Eldean, ZS
    Kabbani, W
    Philip, P
    Shields, A
    Vaitkevicius, V
    Adsay, NV
    LABORATORY INVESTIGATION, 2001, 81 (01) : 201A - 201A